$2.58T
Total marketcap
$174.33B
Total volume
BTC 50.03%     ETH 15.87%
Dominance

Amylyx Pharmaceuticals AMLX Stock

2.86 USD {{ price }} -11.728398% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
193.86M USD
LOW - HIGH [24H]
2.76 - 3.15 USD
VOLUME [24H]
5.53M USD
{{ volume }}
P/E Ratio
4.08
Earnings per share
0.7 USD

Amylyx Pharmaceuticals Price Chart

Amylyx Pharmaceuticals AMLX Financial and Trading Overview

Amylyx Pharmaceuticals stock price 2.86 USD
Previous Close 24.89 USD
Open 24.77 USD
Bid 0 USD x 800
Ask 0 USD x 1000
Day's Range 24.51 - 24.99 USD
52 Week Range 15.8 - 41.93 USD
Volume 971.95K USD
Avg. Volume 941.95K USD
Market Cap 1.66B USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) 0.7 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 49.17 USD

AMLX Valuation Measures

Enterprise Value 1.33B USD
Trailing P/E N/A
Forward P/E 8.5379305
PEG Ratio (5 yr expected) 0.54
Price/Sales (ttm) 17.759083
Price/Book (mrq) 4.710807
Enterprise Value/Revenue 14.223
Enterprise Value/EBITDA -8.599

Trading Information

Amylyx Pharmaceuticals Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 38.86%
S&P500 52-Week Change 20.43%
52 Week High 41.93 USD
52 Week Low 15.8 USD
50-Day Moving Average 27.75 USD
200-Day Moving Average 32.29 USD

AMLX Share Statistics

Avg. Volume (3 month) 941.95K USD
Avg. Daily Volume (10-Days) 742.75K USD
Shares Outstanding 67.18M
Float 40.05M
Short Ratio 7.76
% Held by Insiders 23.46%
% Held by Institutions 81.98%
Shares Short 8.8M
Short % of Float 17.50%
Short % of Shares Outstanding 13.10%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -159.039%
Operating Margin (ttm) -166.11%
Gross Margin -9.43%
EBITDA Margin -165.41%

Management Effectiveness

Return on Assets (ttm) -28.49%
Return on Equity (ttm) -50.18%

Income Statement

Revenue (ttm) 93.66M USD
Revenue Per Share (ttm) 1.5 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -74213000 USD
EBITDA -154924000 USD
Net Income Avi to Common (ttm) -148954000 USD
Diluted EPS (ttm) -2.4
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 345.67M USD
Total Cash Per Share (mrq) 5.15 USD
Total Debt (mrq) 5.79M USD
Total Debt/Equity (mrq) 1.64 USD
Current Ratio (mrq) 7.537
Book Value Per Share (mrq) 5.256

Cash Flow Statement

Operating Cash Flow (ttm) -144308992 USD
Levered Free Cash Flow (ttm) -84066496 USD

Profile of Amylyx Pharmaceuticals

Country United States
State MA
City Cambridge
Address 43 Thorndike Street
ZIP 02141
Phone 617 682 0917
Website https://amylyx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 296

Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Q&A For Amylyx Pharmaceuticals Stock

What is a current AMLX stock price?

Amylyx Pharmaceuticals AMLX stock price today per share is 2.86 USD.

How to purchase Amylyx Pharmaceuticals stock?

You can buy AMLX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Amylyx Pharmaceuticals?

The stock symbol or ticker of Amylyx Pharmaceuticals is AMLX.

Which industry does the Amylyx Pharmaceuticals company belong to?

The Amylyx Pharmaceuticals industry is Biotechnology.

How many shares does Amylyx Pharmaceuticals have in circulation?

The max supply of Amylyx Pharmaceuticals shares is 67.78M.

What is Amylyx Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Amylyx Pharmaceuticals PE Ratio is 4.08571430 now.

What was Amylyx Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Amylyx Pharmaceuticals EPS is 0.7 USD over the trailing 12 months.

Which sector does the Amylyx Pharmaceuticals company belong to?

The Amylyx Pharmaceuticals sector is Healthcare.

Amylyx Pharmaceuticals AMLX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD